UroViu Corporation specializes in innovative endoscopic technologies designed for urology, urogynecology, and gynecology. Their flagship product, the Uro-GHD, is a high-definition, single-use cystoscope that offers enhanced visualization and eliminates the need for reprocessing, thereby improving workflow and reducing procedure times. The UroViu platform is portable and battery-powered, allowing it to be used in various settings without the need for extensive setup or disinfection protocols. This technology not only enhances patient comfort but also addresses the challenges associated with traditional reusable scopes, such as cross-contamination and equipment malfunctions.

In addition to the Uro-GHD, UroViu offers a range of single-use cystoscopes, including the Uro-G, Uro-N, and Uro-V, each designed to meet specific clinical needs. These products are characterized by their ease of use, consistent performance, and the ability to provide clear, detailed images during procedures. The company emphasizes the cost-effectiveness of its single-use models, which eliminate the need for large capital investments and ongoing maintenance associated with reusable equipment. Overall, UroViu's technologies aim to streamline endoscopic procedures while enhancing safety and patient satisfaction.

United States

UroViu Corporation's mission is to revolutionize the cystoscopy platform for improved patient care and efficiency and has operations in California and Washington and production facilities in Asia. UroViu is the developer of the always ready cystoscopy platform, the most portable, self-contained and versatile single-use cystoscopy solution on the market. The intuitive portable platform and product suite are protected by a portfolio of 13 granted and many more pending patents. UroViu's vision is to simplify the scope of patient care.

UroViu Corporation

Company Details